Innate Pharma
(OTC) IPHYF
Innate Pharma Financials at a Glance
Market Cap
$128.67M
Revenue (TTM)
$18.60M
Net Income (TTM)
$98.64M
EPS (TTM)
$-0.61
P/E Ratio
-2.23
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Price
$1.37
Volume
100
Open
$1.37
Price
$1.37
Volume
100
Open
$1.37
Previous Close
$1.37
Daily Range
$1.37 - $1.37
52-Week Range
$1.31 - $2.15
Dividend
$0.00
Beta (Volatility)
-0.05 (Low)
Price
$1.37
Volume
100
Open
$1.37
Previous Close
$1.37
Daily Range
$1.37 - $1.37
52-Week Range
$1.31 - $2.15
IPHYF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Innate Pharma
Industry
Biotechnology
Sector
Health CareEmployees
163
CEO
Jonathan Dickinson, MBA
Website
www.innate-pharma.comHeadquarters
Marseille, 13009, FR
IPHYF Financials
Key Financial Metrics (TTM)
Gross Margin
100%
Operating Margin
-21%
Net Income Margin
-18%
Return on Equity
-271%
Return on Capital
-2%
Return on Assets
-78%
Earnings Yield
-44.84%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$128.67M
Shares Outstanding
93.75M
Volume
100
Short Interest
0.00%
Avg. Volume
2.661
Financials (TTM)
Gross Profit
$2.79M
Operating Income
$53.42M
EBITDA
$43.65M
Operating Cash Flow
$52.74M
Capital Expenditure
$139.95K
Free Cash Flow
$52.88M
Cash & ST Invst.
$34.30M
Total Debt
$22.56M
Innate Pharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$1.12M
-94.8%
Gross Profit
$18.45M
+690.1%
Gross Margin
16.54%
N/A
Market Cap
$128.67M
N/A
Market Cap/Employee
$710.89K
N/A
Employees
181
N/A
Net Income
$27.82M
-199.6%
EBITDA
$18.59M
-78.8%
Quarterly Fundamentals
Net Cash
$11.73M
-77.7%
Accounts Receivable
$12.40M
-73.3%
Inventory
$0.00
N/A
Long Term Debt
$13.77M
-55.5%
Short Term Debt
$8.80M
-1.5%
Return on Assets
-78.41%
N/A
Return on Invested Capital
-2.20%
N/A
Free Cash Flow
$21.66M
-2.5%
Operating Cash Flow
$21.58M
-2.3%